Advertisement

World Journal of Urology

, Volume 31, Issue 5, pp 1253–1259 | Cite as

Holmium laser ablation of the prostate (HoLAP): intermediate-term results of 144 patients

  • D. BarskiEmail author
  • M. Richter
  • C. Winter
  • C. Arsov
  • P. de Geeter
  • R. Rabenalt
  • P. Albers
Original Article

Abstract

Purpose

To retrospectively analyse the intermediate-term outcome of holmium laser ablation of the prostate (HoLAP) of up to 4 years postoperatively in one of the largest series and to define the selection criteria for patients who benefit from potentially lower complications associated with HoLAP.

Methods

Between June 2006 and November 2010, 144 patients with benign prostatic obstruction were treated at two centres with standardised HoLAP (2.0 J/50 Hz or 3.2 J/25 Hz with Versapulse® 80–100 W laser Lumenis®). Median follow-up was 21 months (range, 1–54). International prostate symptom score and quality of life (IPSS-QoL), PSA, prostate volume, maximal flow rate (Qmax), postvoiding residual volume (Vres) were evaluated pre- and postoperatively. All complications were graded according to CTCAE (v4.03).

Results

Mean patient age was 70.1 ± 7.7 years (range, 46–90). With a preoperative median prostate volume of 40 ml (range, 10–130), the median operation time was 50 min (range, 9–138). We observed a median catheterisation time of 1 day (range, 0–12) and hospitalisation time of 2 days (range, 1–16). IPSS-QoL, Qmax and Vres were significantly improved after 3 months, and all parameters remained unchanged after 12, 24 and 36 months. The rate of re-operation was significantly lower in patients with prostate volume <40 ml, compared to patients with prostates ≥40 ml (9.1 vs. 25 %, p = 0.04).

Conclusions

HoLAP is a safe and effective procedure for the treatment of prostates <40 ml. Patients benefit from HoLAP because of a low bleeding rate and short hospital stay. Due to high recurrence rates, HoLAP should be avoided in prostates >40 ml.

Keywords

Benign prostatic hyperplasia BPH HoLAP Holmium laser Ablation of the prostate 

Notes

Conflict of interest

The authors certify that there is no actual or potential conflict of interest in relation to this article.

References

  1. 1.
    Ahyai SA, Lehrich K, Kuntz RM (2007) Holmium laser enucleation versus transurethral resection of the prostate: 3-year follow up results of a randomized clinical trial. Eur Urol 52:1456–1463PubMedCrossRefGoogle Scholar
  2. 2.
    Bach T, Xia SJ, Yang Y et al (2010) Thulium: YAG 2 mum cw laser prostatectomy: where do we stand? World J Urol 28(2):163–168PubMedCrossRefGoogle Scholar
  3. 3.
    Elmansy HM, Elzayat E, Elhilali MM (2010) Holmium laser ablation versus photoselective vaporization of prostate <60 cc: long-term results of a randomized trial. J Urol 184:2023–2028PubMedCrossRefGoogle Scholar
  4. 4.
    Gilling PJ, Cass CB, Cresswell MD et al (1996) Holmium laser resection of the prostate: preliminary results of a new method for the treatment of benign prostatic hyperplasia. Urology 47:48–51PubMedCrossRefGoogle Scholar
  5. 5.
    Gilling PJ, Cass CB, Cresswell MD et al (1996) The use of the holmium laser in the treatment of benign prostatic hyperplasia. J Endourol 10:459–461PubMedCrossRefGoogle Scholar
  6. 6.
    Gilling PJ, Cass CB, Malcolm AR et al (1995) Combination holmium and Nd:YAG laser ablation of the prostate: initial clinical experience. J Endourol 9:151–153PubMedCrossRefGoogle Scholar
  7. 7.
    Herrmann TR, Liatsikos EN, Nagele U et al (2012) EAU guidelines panel on lasers, technologies. Eur Urol 61(4):783–795PubMedCrossRefGoogle Scholar
  8. 8.
    Kuntz RM (2006) Current role of lasers in the treatment of benign prostatic hyperplasia (BPH). Eur Urol 49:961–969PubMedCrossRefGoogle Scholar
  9. 9.
    Kuntz RM, Ahyai S, Lehrich K et al (2004) Transurethral holmium laser enucleation of the prostate versus transurethral electrocautery resection of the prostate: a randomized prospective trial in 200 patients. J Urol 172:1012–1016PubMedCrossRefGoogle Scholar
  10. 10.
    Lourenco T, Pickard R, Vale L et al (2008) Alternative approaches to endoscopic ablation for benign enlargement of the prostate: systematic review of randomised controlled trials. BMJ 337:a449PubMedCrossRefGoogle Scholar
  11. 11.
    Mottet N, Anidjar M, Bourdon O et al (1999) Randomized comparison of transurethral electroresection and holmium: YAG laser vaporization for symptomatic benign prostatic hyperplasia. J Endourol 13:127–130PubMedCrossRefGoogle Scholar
  12. 12.
    Oelke M, Burger M, Castro-Diaz D et al (2011) Diagnosis and medical treatment of lower urinary tract symptoms in adult men: applying specialist guidelines in clinical practice. BJU Int. doi: 10.1111/j.1464-410X.2011.10808.x
  13. 13.
    Richter M, Schwarz J, De Geeter P et al (2009) Holmium laser ablation of the prostate. An alternative to GreenLight photoselective vaporization of the prostate. Urologe A 48:291–295PubMedCrossRefGoogle Scholar
  14. 14.
    Ruszat R, Seitz M, Wyler SF et al (2008) (2008) GreenLight laser vaporization of the prostate: single-center experience and long-term results after 500 procedures. Eur Urol 54:893PubMedCrossRefGoogle Scholar
  15. 15.
    Ruszat R, Seitz M, Wyler SF et al (2009) Prospective single-centre comparison of 120-W diode-pumped solid-state high-intensity system laser vaporization of the prostate and 200-W high-intensive diode-laser ablation of the prostate for treating benign prostatic hyperplasia. BJU Int 104:820–825PubMedCrossRefGoogle Scholar
  16. 16.
    Seki N, Naito S (2008) Holmium laser for benign prostatic hyperplasia. Curr Opin Urol 18:41–45PubMedCrossRefGoogle Scholar
  17. 17.
    Tan AH, Gilling PJ, Kennett KM et al (2003) Long-term results of high-power holmium laser vaporization (ablation) of the prostate. BJU Int 92:707–709PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2012

Authors and Affiliations

  • D. Barski
    • 1
    Email author
  • M. Richter
    • 2
  • C. Winter
    • 3
  • C. Arsov
    • 3
  • P. de Geeter
    • 4
  • R. Rabenalt
    • 3
  • P. Albers
    • 3
  1. 1.Department of UrologyDuesseldorf University HospitalDüsseldorfGermany
  2. 2.Department of UrologyNephrological Center NiedersachsenHannoversch MuendenGermany
  3. 3.Department of UrologyDuesseldorf University HospitalDuesseldorfGermany
  4. 4.Department of UrologyAcademic Hospital Kassel GmbHKasselGermany

Personalised recommendations